Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

39.49
Delayed Data
As of 3:59pm ET
 -0.72 / -1.79%
Today’s Change
31.08
Today|||52-Week Range
80.25
-48.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues62.2M69.3M65.5M69.6M
 
 
 
 
 
Cost of Goods Sold13.0M16.3M17.1M19.8M
 
 
 
 
 
Depreciation And Amortization2.9M3.1M3.2M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income46.3M49.9M45.2M46.6M
 
 
 
 
 
General Expenses41.2M50.7M47.5M53.0M
 
 
 
 
 
Research And Development5.9M13.2M9.5M9.4M
 
 
 
 
 
Total Operating Expenses57.1M70.1M67.7M76.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income5.1M-813.0K-2.3M-6.4M
 
 
 
 
 
Extraordinary Charge0.00-1.0K0.000.00
 
 
Interest Expense On Debt2.1M2.1M2.1M2.1M
 
 
 
 
 
Other Expenses-8.0K-83.0K48.0K-47.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.4M-2.6M-3.8M-7.9M
 
 
 
 
 
Income Taxes-281.0K-108.0K-32.0K-58.0K
 
 
 
 
 
Net Income3.1M-2.5M-3.9M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.7M36.8M37.0M37.2M
 
 
 
 
 
Shares To Calculate EPS Diluted41.0M36.8M37.0M37.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.08-$0.07-$0.10-$0.21
 
 
 
 
 
EPS Diluted$0.08-$0.07-$0.10-$0.21